Nnamdi Etoh
@Rock Springs Capital Management Lp
Latest period2024 - Q3ReportedManaged Assets$3.074BTotal holdings109
Assets growth rate-7.48%Assets growth rate (2-Q avg)-11.56%Continuous growth in asset value0 quarters
Portfolio positions
This chart displays the top 10 holdings in Rock Springs Capital Management Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 109 positions.
Assets under management
The assets under management (AUM) of Rock Springs Capital Management Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 3.074B in assets, with a quarterly growth rate of -7.48% and a 2-quarter average growth rate of -11.56%. The portfolio is managed by Nnamdi Etoh, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
INSMInsmed Inc
| 1.63% | $49.884M 683,344 shares@ $73.0 avg price | Decreased -15.46% |
KYMRKymera Therapeutics Inc
| 1.62% | $49.667M 1.049M shares@ $47.33 avg price | Decreased -9.84% |
ASNDAscendis Pharma A S
| 1.58% | $48.526M 325,000 shares@ $149.31 avg price | Increased 12.07% |
HUMHumana Inc
| 1.53% | $46.878M 148,000 shares@ $316.74 avg price | Increased 0.41% |
GPCRStructure Therapeutics Inc
| 1.52% | $46.695M 1.064M shares@ $43.9 avg price | Decreased -0.14% |
RVMDRevolution Medicines Inc
| 1.5% | $45.801M 1.01M shares@ $45.36 avg price | Increased 7.08% |
MRUSMerus N V
| 1.46% | $44.592M 892,549 shares@ $49.96 avg price | Decreased -10.84% |
NUVLNuvalent Inc
| 1.44% | $43.988M 429,994 shares@ $102.3 avg price | Increased 67.98% |
MREOMereo Biopharma Group Plc
| 1.28% | $39.185M 9.534M shares@ $4.12 avg price | Increased 2.71% |
BSXBoston Scientific Corp
| 1.26% | $38.548M 460,000 shares@ $83.8 avg price | Decreased -43.73% |